Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_provenance.
- NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_assertion description "[These results indicate that PEP-1-FK506BP inhibits inflammatory response cytokines and enzymes by blocking NF-?B and MAPK including the phosphorylation of p38 and/or ERK MAPK in vitro and in vivo, suggesting that PEP-1-FK506BP may be a therapeutic agent against inflammatory skin diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_provenance.
- NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_assertion evidence source_evidence_literature NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_provenance.
- NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_assertion SIO_000772 21288594 NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_provenance.
- NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_assertion wasDerivedFrom befree-20140225 NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_provenance.
- NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_assertion wasGeneratedBy ECO_0000203 NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_provenance.
- befree-20140225 importedOn "2014-02-25" NP384852.RANX1qOZUW0VFaF6ZdigElS5n2nGLvpkTvzITHdXvta_c130_provenance.